New Data on Terlipressin Presented at DDW 2025 | Docwire News
Peter Richardson and George Wan of Mallinckrodt discussed data on terlipressin for hepatorenal syndrome–acute kidney injury (HRS-AKI) presented at Digestive Disease Week 2025.
Peter Richardson and George Wan of Mallinckrodt discussed data on terlipressin for hepatorenal syndrome–acute kidney injury (HRS-AKI) presented at Digestive Disease Week 2025.
And what should you have, if you’re a health guy?
A nursing team shared insights on operationalizing a new gene therapy for bladder cancer, nadofaragene firadenovec (Adstiladrin), through a multidisciplinary approach.
Highlights •This systematic review provides an overview of all experimental HCM models from 1977 to 2023 and highlights if models show main human disease characteristics.•Since…
A study assessed whether proton pump inhibitor (PPI) use accelerated chronic kidney disease (CKD) progression and acute kidney injury (AKI) risk.
Although there is a growing number of people living with advanced or metastatic cancer, primarily because of more effective treatment regimens, there are limited estimates…
Researchers evaluated the use of disitamab vedotin with toripalimab in improving survival in patients with advanced UC.
Introduction: Advanced glycation end products (AGEs) are non-enzymatically formed through reactions between sugars and proteins. Over the past decades, accumulating evidence has linked AGEs to…
AbstractBackgroundRhythm control in atrial fibrillation (AF) can be achieved with catheter ablation, but arrhythmia recurrences can require further interventions.ObjectivesThe aim of this study was…
location_on McCormick Place, Chicago, IL & Online Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration…
AbstractBackgroundMost patients at high-risk for cardiovascular events do not achieve lipid goals advocated by American College of Cardiology/American Heart Association (ACC/AHA) guidelines despite…